Alliance for Cancer Gene Therapy meets the 20 Standards for Charity Accountability.
Alliance for Cancer Gene Therapy (ACGT) supports cell and gene therapy research for cancer that meets the highest possible standards. The organization reports that it educates the public on the potential for cell and gene medicines for cancer and facilitates collaboration among the scientific, investment and philanthropic communities to promote progress in the field of cell and gene therapy for cancer.
For the year ended April 30, 2018, Alliance for Cancer Gene Therapy's program expenses were:
Research grants and awards |
$1,758,650 |
Total Program Expenses: |
$1,758,650 |
*2018 compensation, as reported by the organization, includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Invitations to fund raising events
Fundraising costs were 11% of related contributions. (Related contributions, which totaled $2,031,070, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Alliance for Cancer Gene Therapy's audited financial statements for the year ended April 30, 2018.
Source of Funds |
Contributions |
$1,151,343 |
Contributed services |
$768,597 |
Net realized gains on investments |
$498,191 |
Special events |
$111,130 |
Interest and dividend income |
$104,912 |
Total Income |
$2,634,173 |
- Programs: 74%
- Administrative: 17%
- Fundraising: 9%
Total Income |
$2,634,173 |
Program expenses |
$1,758,650 |
Fundraising expenses |
$232,381 |
Administrative expenses |
$386,953 |
Other expenses |
$0 |
Total expenses: |
$2,377,984 |
Income in Excess of Expenses |
$256,189 |
Beginning Net Assets |
$4,567,096 |
Other Changes In Net Assets |
$0 |
Ending Net Assets |
$4,823,285 |
Total Liabilities |
$1,753,021 |
Total Assets |
$6,576,306 |